Sign in or create an account to add this stock to your watchlist.
About CRH Medical (NYSEAMERICAN:CRHM)
CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid. The company also offers anesthesia services for patients undergoing endoscopic procedures. It distributes the CRH O'Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to gastroenterology practices. The company was formerly known as Medsurge Medical Products Corp. and changed its name to CRH Medical Corporation in April 2006. CRH Medical Corporation was founded in 2000 and is headquartered in Vancouver, Canada.
Industry, Sector and Symbol
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
SymbolNYSEAMERICAN:CRHM
CUSIPN/A
Phone+1-604-6331440
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding Shares72,850,000
CRH Medical (NYSEAMERICAN:CRHM) Frequently Asked Questions
What is CRH Medical's stock symbol?
CRH Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CRHM."
How were CRH Medical's earnings last quarter?
CRH Medical (NYSEAMERICAN:CRHM) announced its quarterly earnings data on Monday, April, 30th. The company reported $0.02 EPS for the quarter, beating the consensus estimate of ($0.01) by $0.03. The firm had revenue of $24.67 million for the quarter, compared to analyst estimates of $21.70 million. View CRH Medical's Earnings History.
When is CRH Medical's next earnings date?
What price target have analysts set for CRHM?
8 analysts have issued twelve-month target prices for CRH Medical's shares. Their predictions range from $5.00 to $5.00. On average, they expect CRH Medical's stock price to reach $5.00 in the next year. View Analyst Ratings for CRH Medical.
Are investors shorting CRH Medical?
CRH Medical saw a decrease in short interest in May. As of May 15th, there was short interest totalling 677,487 shares, a decrease of 25.2% from the April 30th total of 905,315 shares. Based on an average daily volume of 165,751 shares, the days-to-cover ratio is currently 4.1 days. Currently, 1.0% of the company's stock are short sold.
Who are some of CRH Medical's key competitors?
Some companies that are related to CRH Medical include Advanced Medical Solutions (AMS), TransEnterix (TRXC), Tristel (TSTL), TSO3. (TOS), Clover (CLV), Bovie Medical (BVX), Infusystem (INFU), Retractable Technologies (RVP), Milestone Scientific (MLSS), Akers Biosciences (AKR), Daxor (DXR), Omega Diagnostics Group (ODX), Relevium Technologies (RLV), Vigil Health Solutions (VGL) and Iris Biotechnologies (IRSB).
Who are CRH Medical's key executives?
CRH Medical's management team includes the folowing people:
- Mr. Edward Wright, Chief Exec. Officer and Non Independent Director (Age 55)
- Mr. Richard K. Bear, Chief Financial Officer and Corp. Sec. (Age 55)
- Mr. James Kreger, Pres of CRH Anesthesia Management
- Ms. Kettina Cordero, Director of Investor Relations
- Dr. Mitchel Guttenplan M.D., FACS, Medical Director
Has CRH Medical been receiving favorable news coverage?
Media coverage about CRHM stock has been trending positive recently, according to Accern Sentiment. The research firm identifies negative and positive press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. CRH Medical earned a news impact score of 0.36 on Accern's scale. They also assigned media stories about the company an impact score of 47.59 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.
Who are CRH Medical's major shareholders?
CRH Medical's stock is owned by a number of of institutional and retail investors. Top institutional investors include Mawer Investment Management Ltd. (8.02%), Pacific Ridge Capital Partners LLC (3.10%), Stifel Financial Corp (2.97%), JPMorgan Chase & Co. (1.24%), UBS Group AG (0.28%) and Seizert Capital Partners LLC (0.23%). View Institutional Ownership Trends for CRH Medical.
Which institutional investors are selling CRH Medical stock?
Which institutional investors are buying CRH Medical stock?
CRHM stock was purchased by a variety of institutional investors in the last quarter, including Stifel Financial Corp, UBS Group AG, JPMorgan Chase & Co. and Pacific Ridge Capital Partners LLC. View Insider Buying and Selling for CRH Medical.
How do I buy shares of CRH Medical?
Shares of CRHM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is CRH Medical's stock price today?
One share of CRHM stock can currently be purchased for approximately $3.50.
How big of a company is CRH Medical?
CRH Medical has a market capitalization of $229.48 million.
How can I contact CRH Medical?
CRH Medical's mailing address is 57B - 999 Canada Place World Trade Center, VANCOUVER, BC V6C 3E1, Canada. The company can be reached via phone at +1-604-6331440.
MarketBeat Community Rating for CRH Medical (CRHM)
MarketBeat's community ratings are surveys of what our community members think about CRH Medical and other stocks. Vote "Outperform" if you believe CRHM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CRHM will underperform the S&P 500 over the long term. You may vote once every thirty days.
CRH Medical (NYSEAMERICAN:CRHM) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
8 Wall Street analysts have issued ratings and price targets for CRH Medical in the last 12 months. Their average twelve-month price target is $5.00, suggesting that the stock has a possible upside of 42.86%. The high price target for CRHM is $5.00 and the low price target for CRHM is $5.00. There are currently 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 2.63 | 2.63 | 2.67 | 2.67 |
| Ratings Breakdown: | 0 Sell Rating(s)
3 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
3 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
3 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
3 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $5.00 | $5.00 | $7.50 | $7.8333 |
| Price Target Upside: | 42.86% upside | 163.16% upside | 294.74% upside | 312.28% upside |
CRH Medical (NYSEAMERICAN:CRHM) Consensus Price Target History
CRH Medical (NYSEAMERICAN:CRHM) Analyst Ratings History
Show:
(Data available from 5/26/2016 forward)
CRH Medical (NYSEAMERICAN:CRHM) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
CRH Medical (NYSEAMERICAN CRHM) Insider Trading and Institutional Ownership History
CRH Medical (NYSEAMERICAN CRHM) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
(Data available from 1/1/2013 forward)
CRH Medical (NYSEAMERICAN CRHM) News Headlines
| Source: |
|
CRH Medical (NYSEAMERICAN:CRHM) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
CRH Medical (NYSEAMERICAN CRHM) Stock Chart for Saturday, May, 26, 2018
Loading chart…
